These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21567458)

  • 1. Has "levodopa-induced neuropathy" been reported in Parkinson's disease clinical trials?
    Teodoro T; Pires D; Rosa MM; Coelho M; Sampaio C; Ferreira JJ
    Mov Disord; 2011 Aug; 26(10):1966-7. PubMed ID: 21567458
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply: neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.
    Toth C; Suchowersky O; Zochodne D
    Mov Disord; 2010 Mar; 25(4):525. PubMed ID: 20155864
    [No Abstract]   [Full Text] [Related]  

  • 3. "Double crush" in Parkinson's disease.
    Weinberger M; Inzelberg R
    Ann Neurol; 2010 Dec; 68(6):972; author reply 973. PubMed ID: 21194160
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.
    Manca D; Cossu G; Murgia D; Molari A; Ferrigno P; Marcia E; Melis M
    Mov Disord; 2009 Nov; 24(15):2293-4. PubMed ID: 19795477
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical studies with levodopa/carbidopa intestinal gel].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2014 Jan; 67(1-2):5-8. PubMed ID: 24654442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case series of peripheral neuropathy in patients with Parkinson's disease.
    Gondim Fde A; de Oliveira GR; Peixoto AA; Horta WG
    Ann Neurol; 2010 Dec; 68(6):973-5; author reply 975. PubMed ID: 21194162
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.
    Ceravolo R; Cossu G; Bandettini di Poggio M; Santoro L; Barone P; Zibetti M; Frosini D; Nicoletti V; Manganelli F; Iodice R; Picillo M; Merola A; Lopiano L; Paribello A; Manca D; Melis M; Marchese R; Borelli P; Mereu A; Contu P; Abbruzzese G; Bonuccelli U
    Mov Disord; 2013 Sep; 28(10):1391-7. PubMed ID: 23836370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.
    Montastruc JL; Danton AC; Durrieu G; Lacroix I; Olivier P; Sommet A; Senard JM;
    Mov Disord; 2010 Apr; 25(5):660-1. PubMed ID: 20213824
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Other studies have not shown increased mortality.
    Mäki-Ikola O; Kilkku O; Heinonen E
    BMJ; 1996 Mar; 312(7032):702; author reply 704-5. PubMed ID: 8597744
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary.
    Olanow CW; Godbold JH; Koller W
    BMJ; 1996 Mar; 312(7032):702-3; author reply 704-5. PubMed ID: 8597746
    [No Abstract]   [Full Text] [Related]  

  • 11. Ropinirole as compared with levodopa in Parkinson's disease.
    Weiner WJ; Factor SA
    N Engl J Med; 2000 Sep; 343(12):885. PubMed ID: 11001687
    [No Abstract]   [Full Text] [Related]  

  • 12. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease.
    Toth C; Breithaupt K; Ge S; Duan Y; Terris JM; Thiessen A; Wiebe S; Zochodne DW; Suchowersky O
    Ann Neurol; 2010 Jul; 68(1):28-36. PubMed ID: 20582991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ropinirole as compared with levodopa in Parkinson's disease.
    Yamamoto T
    N Engl J Med; 2000 Sep; 343(12):884; author reply 885. PubMed ID: 11001685
    [No Abstract]   [Full Text] [Related]  

  • 14. Ropinirole as compared with levodopa in Parkinson's disease.
    Frucht S
    N Engl J Med; 2000 Sep; 343(12):885. PubMed ID: 11001686
    [No Abstract]   [Full Text] [Related]  

  • 15. Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery.
    Müller T; van Laar T; Cornblath DR; Odin P; Klostermann F; Grandas FJ; Ebersbach G; Urban PP; Valldeoriola F; Antonini A
    Parkinsonism Relat Disord; 2013 May; 19(5):501-7 ; discussion 501. PubMed ID: 23453891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ropinirole as compared with levodopa in Parkinson's disease.
    Hiner BC; Earnhart M
    N Engl J Med; 2000 Sep; 343(12):884; author reply 885. PubMed ID: 11001684
    [No Abstract]   [Full Text] [Related]  

  • 17. Levodopa elevates homocysteine: is this a problem?
    O'Suilleabhain P; Diaz-Arrastia R
    Arch Neurol; 2004 May; 61(5):633-4. PubMed ID: 15148136
    [No Abstract]   [Full Text] [Related]  

  • 18. Current controversies: levodopa in the treatment of Parkinson's disease.
    Sharma JC; Vassallo M; Ross IN
    Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129
    [No Abstract]   [Full Text] [Related]  

  • 19. [Updates in practical neurology--I. The principles of modern levodopa therapy in Parkinson's disease].
    Klivényi P; Vécsei L
    Ideggyogy Sz; 2007 Jan; 60(1-2):61-4. PubMed ID: 17432097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa--toxic or neuroprotective?
    Weiner WJ
    Nat Clin Pract Neurol; 2006 Oct; 2(10):518-9. PubMed ID: 16990820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.